Cerebral palsy affects approximately 17 million people worldwide, making it the most common cause of physical disability in childhood. Yet for most families and clinicians, management tends to center on symptom control — physiotherapy, antispasticity medications, surgical procedures — with relatively little attention to the biological signals that drive individual variation in outcomes.

Amyotrophic lateral sclerosis is one of the most challenging diagnoses in neurology. It moves fast, it speaks loudly, and it leaves patients, families, and clinicians searching for traction in an area where traction has historically been difficult to find.

Multiple Pterygium Syndrome (MPS) is one of those conditions where the name barely hints at what daily life actually looks like for those navigating it. The characteristic skin webs (pterygia) that form across joints — most often the neck, knees, elbows, and fingers — are striking, but they represent only the visible surface of a condition that runs far deeper.